Short Interest in Merck KGaA (OTCMKTS:MKGAF) Grows By 19.7%

Merck KGaA (OTCMKTS:MKGAF) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 284,600 shares, an increase of 19.7% from the October 15th total of 237,800 shares. Based on an average trading volume of 300 shares, the short-interest ratio is currently 948.7 days.

Merck KGaA Stock Performance

MKGAF stock traded down $2.00 during midday trading on Friday, reaching $150.00. 253 shares of the company were exchanged, compared to its average volume of 513. Merck KGaA has a one year low of $144.73 and a one year high of $200.56. The firm has a market capitalization of $19.39 billion, a price-to-earnings ratio of 22.03 and a beta of 0.96. The business has a 50-day moving average price of $170.99 and a two-hundred day moving average price of $175.92. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded Merck KGaA to a “strong-buy” rating in a report on Thursday, September 19th.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.